Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) traded up 15.1% during mid-day trading on Monday . The company traded as high as GBX 1.75 ($0.02) and last traded at GBX 1.59 ($0.02). 1,058,213 shares were traded during mid-day trading, a decline of 6% from the average session volume of 1,131,747 shares. The stock had previously closed at GBX 1.38 ($0.02).
Cizzle Biotechnology Trading Up 1.6%
The company has a market cap of £6.21 million, a PE ratio of -2,197.88 and a beta of 0.38. The business has a 50 day simple moving average of GBX 1.55 and a two-hundred day simple moving average of GBX 1.63.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Buffett’s Cash Hoard Signals Market Caution, Value Plays Emerge
- Manufacturing Stocks Investing
- DLocal Stock Soars 43% After Earnings Beat and Raised Guidance
- How to Calculate Inflation Rate
- Can AI Defense Contracts Push Palantir Shares Higher?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
